A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients (Q40116046)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
scientific article

    Statements

    A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients (English)
    Pedro C Rodriguez
    Odeth Martínez
    Eduardo Santiesteban
    Ricardo Fleytas
    Soraida C Acosta
    Ana de la Torre
    Delmairis Reyes
    Teresa Sabates
    Mauricio Catala
    Yoanna I Flores
    Beatriz Garcia
    Patricia Lorenzo-Luaces
    Maria A Marrero
    Nadia Aguilera
    Yaisel Pomares
    Patricia Sierra
    Gryssell Rodríguez

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit